The Adherence and LDL-C Lowering Effect of Inclisiran Among Patients Who Received Treatment at Outpatient Clinics

被引：0
|
作者：
Desai, Nihar R.
Van Hise, Nicholas
Niu, Charlene
Ghera, Elizabeth
McElligott, Sean
机构：
来源：
CIRCULATION | 2023年 / 148卷
关键词：
Atherosclerosis; Dyslipidemia; LDL; Cholesterol-lowering drugs; Cardiovascular disease;
D O I：
10.1161/circ.148.suppl_1.16180
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A16180
引用
收藏
页数：2
相关论文
共 50 条
  • [21] REDUCTIONS IN LDL-C WITHIN THE FIRST YEAR OF TREATMENT WITH INCLISIRAN: RESULTS FROM A MULTICENTER REAL WORLD COHORT
    Ballantyne, Christie M.
    Varisco, Tyler
    Graham, Timothy
    Iteld, Bruce J.
    Serota, Harvey
    McElligott, Sean
    Niu, Xiaoli
    Hanna, Kelly
    Van Anglen, Lucinda
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 1941 - 1941
  • [22] VARIABILITY OF TIME-RELATED PERCENTAGE CHANGE IN LDL-C WITH INCLISIRAN IN STABLE CORONARY ARTERY DISEASE PATIENTS
    Trusinskis, Karlis
    Kokina, Baiba
    Lapsovs, Maris
    Caunite, Laima
    Knoka, Evija
    Karantajere, Mairita
    Kumsars, Indulis
    Jegere, Sanda
    Mintale, Iveta
    Sondore, Dace
    Narbute, Inga
    Erglis, Andrejs
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 1131 - 1131
  • [23] Adherence to statin therapy and LDL-C goal attainment by patients with diabetes and dyslipidemia
    Parris, ES
    Lawrence, DB
    Mohn, LA
    Long, LB
    DIABETES, 2004, 53 : A289 - A289
  • [24] THE CHANGE OF LDL-C AND TREATMENT PATTERNS AMONG DOCUMENTED CAD/MI PATIENTS WHO UNDERWENT CAG IN TAIWAN: A RETROSPECTIVE COHORT STUDY
    Chen, C. M.
    Hsu, C-Y
    Lin, H-J
    Chen, H-M
    Yang, Y-H
    Chen, W-J
    Hsiao, F-Y
    Chen, W-J
    ATHEROSCLEROSIS, 2022, 355 : E185 - E185
  • [25] Effect of statin treatment on LDL-C/HDL-C goal attainment
    Crouse, JR
    Alexander, CM
    Weiss, TW
    Lu, JD
    Lattin, GM
    Krantzler, JD
    Markson, LE
    CIRCULATION, 2001, 104 (17) : 829 - 829
  • [26] Consistency of LDL-C lowering effect across subgroups of ezetimibe co-administered with statins
    Lipka, L
    Melani, L
    LeBeaut, A
    Sun, S
    Suresh, R
    Veltri, E
    EUROPEAN HEART JOURNAL, 2002, 23 : 19 - 19
  • [27] COST-EFFECTIVENESS OF AGGRESSIVE LDL-C LOWERING FOR ACUTE CORONARY SYNDROM PATIENTS IN FRANCE
    de Pouvourville, G.
    Gueron, B.
    de Gendre, A. Solesse
    ATHEROSCLEROSIS SUPPLEMENTS, 2008, 9 (01) : 206 - 206
  • [28] Effect of Ezetimibe on LDL-C Lowering and Atherogenic Lipoprotein Profiles in Type 2 Diabetic Patients Poorly Controlled by Statins
    Sakamoto, Kentaro
    Kawamura, Mitsunobu
    Kohro, Takahide
    Omura, Masao
    Watanabe, Takayuki
    Ashidate, Keiko
    Horiuchi, Toshiyuki
    Hara, Hidehiko
    Sekine, Nobuo
    Chin, Rina
    Tsujino, Motoyoshi
    Hiyoshi, Toru
    Tagami, Motoki
    Tanaka, Akira
    Mori, Yasumichi
    Inazawa, Takeshi
    Hirano, Tsutomu
    Yamazaki, Tsutomu
    Shiba, Teruo
    PLOS ONE, 2015, 10 (09):
  • [29] Current Choice for LDL-C Lowering in High-Risk CVD Patients Intolerant to Statins
    Fras, Zlatko
    CURRENT VASCULAR PHARMACOLOGY, 2021, 19 (04) : 398 - 402
  • [30] LDL-C Values and Lipid Lowering Therapy Utilization Among Medicare Beneficiaries With a Recent Myocardial Infarction
    Desai, Nihar R.
    DiMario, Stefan
    Schludi, Belinda
    Habib, Mohdhar
    Mues, Katie
    Dietz, Kevin
    Shen, Xian
    CIRCULATION, 2019, 140
12345